Continental Pellets Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 16.49%
- Profit Growth 4.38%
- Ebitda 3.17%
- Net Worth 27.42%
- Total Assets -14.54%
About Continental Pellets Pharma
Continental Pellets Pharma Private Limited (CPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2020 (Four years and 11 months 14 days old ). Its registered office is in K.V.Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
K.V.Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100TG2020PTC139385
-
Company No.
139385
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Continental Pellets Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seelam Manojkumarreddy
|
Director | 20-Feb-2020 | Current |
|
Savitri Tulluri
|
Director | 20-Feb-2020 | Current |
|
Venkat Marakala
|
Director | 20-Feb-2020 | Current |
Financial Performance of Continental Pellets Pharma.
Continental Pellets Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.49% increase. The company also saw a slight improvement in profitability, with a 4.38% increase in profit. The company's net worth Soared by an impressive increase of 27.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Continental Pellets Pharma?
Unlock access to Continental Pellets Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Concord Drugs LimitedSeelam Manojkumarreddy is a mutual person
-
Cortex Laboratories Private LimitedSeelam Manojkumarreddy is a mutual person
-
Proton Remedies Private Limited
Seelam Manojkumarreddy is a mutual person
-
Seelam Laboratories Private Limited
Seelam Manojkumarreddy is a mutual person
-
Pelcygnus Formulations Private Limited
Savitri Tulluri and Venkat Marakala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Continental Pellets Pharma?
Unlock and access historical data on people associated with Continental Pellets Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Continental Pellets Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Continental Pellets Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
